Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.96)
# 115
Out of 4,835 analysts
645
Total ratings
56.9%
Success rate
35.7%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Rated: Buy | $12 | $7.45 | +61.07% | 30 | Sep 10, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $8 | $4.57 | +75.05% | 45 | Sep 8, 2026 | |
| BFLY Butterfly Network | Reiterated: Buy | $10 | $7.33 | +36.43% | 25 | Sep 2, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $4 | $0.64 | +525.00% | 3 | Sep 2, 2026 | |
| CELC Celcuity | Reiterated: Buy | $178 → $173 | $83.45 | +107.31% | 29 | Aug 18, 2026 | |
| GRCE Grace Therapeutics | Reiterated: Buy | $4 | $2.22 | +80.18% | 20 | Aug 18, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $17 | $8.90 | +91.01% | 5 | Aug 14, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $62 → $76 | $57.08 | +33.15% | 39 | Aug 14, 2026 | |
| FENC Fennec Pharmaceuticals | Rated: Buy | $18 | $10.95 | +64.46% | 34 | Aug 12, 2026 | |
| XTNT Xtant Medical Holdings | Rated: Buy | $0.6 | $0.3458 | +73.51% | 38 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.88 | - | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $15.78 | +52.09% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $18 | $12.99 | +38.57% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.16 | +89.87% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.1 → $1.7 | $1.30 | +30.77% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 | $34.49 | +53.67% | 38 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $8.36 | +139.23% | 35 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.15 | +133.01% | 19 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.08 | - | 33 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $34.48 | +71.11% | 45 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.73 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.72 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.45 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.74 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.40 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.84 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $167.24 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.57 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.22 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $284.47 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.21 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.15 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $94.69 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.19 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.31 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.62 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $32.79 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $20.51 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.42 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.07 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.10 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.47 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $23.16 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $12.15 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $33.23 | n/a | 1 | May 3, 2023 |
Xeris Biopharma Holdings
Sep 10, 2026
Rated: Buy
Price Target: $12
Current: $7.45
Upside: +61.07%
MiMedx Group
Sep 8, 2026
Reiterated: Buy
Price Target: $8
Current: $4.57
Upside: +75.05%
Butterfly Network
Sep 2, 2026
Reiterated: Buy
Price Target: $10
Current: $7.33
Upside: +36.43%
Fractyl Health
Sep 2, 2026
Reiterated: Buy
Price Target: $4
Current: $0.64
Upside: +525.00%
Celcuity
Aug 18, 2026
Reiterated: Buy
Price Target: $178 → $173
Current: $83.45
Upside: +107.31%
Grace Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $2.22
Upside: +80.18%
Alpha Cognition
Aug 14, 2026
Reiterated: Buy
Price Target: $17
Current: $8.90
Upside: +91.01%
Eton Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $62 → $76
Current: $57.08
Upside: +33.15%
Fennec Pharmaceuticals
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $10.95
Upside: +64.46%
Xtant Medical Holdings
Aug 12, 2026
Rated: Buy
Price Target: $0.6
Current: $0.3458
Upside: +73.51%
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.88
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $15.78
Upside: +52.09%
Aug 6, 2026
Rated: Buy
Price Target: $16 → $18
Current: $12.99
Upside: +38.57%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $3.16
Upside: +89.87%
Aug 6, 2026
Reiterated: Buy
Price Target: $1.1 → $1.7
Current: $1.30
Upside: +30.77%
Aug 4, 2026
Rated: Buy
Price Target: $53
Current: $34.49
Upside: +53.67%
Jul 31, 2026
Rated: Buy
Price Target: $20
Current: $8.36
Upside: +139.23%
Jul 22, 2026
Reiterated: Buy
Price Target: $12
Current: $5.15
Upside: +133.01%
Jul 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.08
Upside: -
Jul 13, 2026
Reiterated: Buy
Price Target: $59
Current: $34.48
Upside: +71.11%
Jul 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.73
Upside: -
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.72
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.45
Upside: -
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.74
Upside: -
Apr 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.40
Upside: -
Nov 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $61.84
Upside: -
Nov 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $167.24
Upside: -
Oct 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $74.57
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $36.22
Upside: -
Oct 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $284.47
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $53.21
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: n/a
Current: $94.69
Upside: n/a
Jul 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.19
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $12
Current: $11.31
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.62
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $32.79
Upside: n/a
Aug 1, 2024
Reiterated: Buy
Price Target: $38
Current: $20.51
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $11.42
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $10
Current: $4.07
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $5.10
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $1.47
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $23.16
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $12.15
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $33.23
Upside: n/a